EMEA-000308-PIP02-11-M01

Key facts

Invented name
MabThera
Active substance
rituximab
Therapeutic area
Oncology
Decision number
P/0060/2016
PIP number
EMEA-000308-PIP02-11-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of microscopic polyangiitis
Route(s) of administration
Intravenous use
Contact for public enquiries
Roche Registration Limited
Switzerland
Tel. +41 616879411
Fax +44 616879411
E-mail: infopaediatrics@roche.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating